Celladon (CLDN) PT Cut to $1.25 at BMO Capital Following Update
Tweet Send to a Friend
BMO Capital analyst Jim Birchenough lowered his price target on Celladon Corp (NASDAQ: CLDN) to $1.25 (from $2.00) while reiterating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
